Gulhan Akbaba1, Dilek Berker2, Serhat Isık2, Mazhar Muslum Tuna2, Suha Koparal3, Murat Vural3, Fatma Meric Yılmaz4, Canan Topcuoglu4, Serdar Guler2,5. 1. Department of Internal Medicine, Endocrinology and Metabolism, Mugla Sıtkı Kocman University School of Medicine, Mugla, Turkey. gulhanakcil@yahoo.com.tr. 2. Clinics of Endocrinology and Diseases of Metabolism, Ankara Numune Education and Research Hospital, Ankara, Turkey. 3. Clinics of Radiology, Ankara Numune Education and Research Hospital, Ankara, Turkey. 4. Clinics of Biochemistry, Ankara Numune Education and Research Hospital, Ankara, Turkey. 5. Faculty of Medicine, Department of Endocrinology and Diseases of Metabolism, Hitit University, Corum, Turkey.
Abstract
BACKGROUND: Subclinical hypothyroidism (SH) occurs when serum thyroid stimulating hormone (TSH) concentrations are raised and serum thyroid hormone concentrations are normal. The effect of SH on the proinflammatory adipose cytokine releasing visceral adipose tissue (VAT) is not clear. The aim of this study is to identify the difference between the pre and posttreatment levels of VAT, leptin, and resistin in SH patients. METHODS: There were 51 SH patients and 43 age- and gender-matched healthy subjects included in the study. Thyroid functions, biochemical tests, leptin, resistin, and visceral and subcutaneous fat measurements were made. The measurements were repeated in the SH group in the third month following L-thyroxin treatment. RESULTS: Initially, high sensitivity C-reactive protein, carotid artery intima-media thickness (mm), leptin, and resistin levels were significantly higher in the SH group compared to the controls, while the other parameters were similar. While no correlation was observed between TSH levels and adipokines, a positive correlation was detected between waist circumference and leptin levels (r = 0.549, p < 0.01). Visceral adipose tissue was positively correlated to age, waist circumference, and leptin levels, but negatively correlated to free thyroxin (T4) levels (r = 0.419, p = 0.009; r = 0.794, p < 0.01; r = 0.515, p < 0.01 and r = - 0.416, p = 0.009, respectively). A significant decrease was observed in VAT volume, leptin, and resistin levels of SH patients following levothyroxine treatment. Conclusion The reduced VAT volume, leptin, and resistin levels in SH patients following treatment may support the idea that TSH affects adipose tissue functions.
BACKGROUND: Subclinical hypothyroidism (SH) occurs when serum thyroid stimulating hormone (TSH) concentrations are raised and serum thyroid hormone concentrations are normal. The effect of SH on the proinflammatory adipose cytokine releasing visceral adipose tissue (VAT) is not clear. The aim of this study is to identify the difference between the pre and posttreatment levels of VAT, leptin, and resistin in SH patients. METHODS: There were 51 SH patients and 43 age- and gender-matched healthy subjects included in the study. Thyroid functions, biochemical tests, leptin, resistin, and visceral and subcutaneous fat measurements were made. The measurements were repeated in the SH group in the third month following L-thyroxin treatment. RESULTS: Initially, high sensitivity C-reactive protein, carotid artery intima-media thickness (mm), leptin, and resistin levels were significantly higher in the SH group compared to the controls, while the other parameters were similar. While no correlation was observed between TSH levels and adipokines, a positive correlation was detected between waist circumference and leptin levels (r = 0.549, p < 0.01). Visceral adipose tissue was positively correlated to age, waist circumference, and leptin levels, but negatively correlated to free thyroxin (T4) levels (r = 0.419, p = 0.009; r = 0.794, p < 0.01; r = 0.515, p < 0.01 and r = - 0.416, p = 0.009, respectively). A significant decrease was observed in VAT volume, leptin, and resistin levels of SH patients following levothyroxine treatment. Conclusion The reduced VAT volume, leptin, and resistin levels in SH patients following treatment may support the idea that TSH affects adipose tissue functions.
Authors: José I Botella-Carretero; Francisco Alvarez-Blasco; José Sancho; Héctor F Escobar-Morreale Journal: Thyroid Date: 2006-04 Impact factor: 6.568
Authors: Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Leonelo Bautista; Maria Grazia Franzosi; Patrick Commerford; Chim C Lang; Zvonko Rumboldt; Churchill L Onen; Liu Lisheng; Supachai Tanomsup; Paul Wangai; Fahad Razak; Arya M Sharma; Sonia S Anand Journal: Lancet Date: 2005-11-05 Impact factor: 79.321
Authors: G E Krassas; N Pontikides; K Loustis; G Koliakos; T Constantinidis; T Kaltsas Journal: J Endocrinol Invest Date: 2006 Jul-Aug Impact factor: 4.256
Authors: F Monzani; N Caraccio; M Kozàkowà; A Dardano; F Vittone; A Virdis; S Taddei; C Palombo; E Ferrannini Journal: J Clin Endocrinol Metab Date: 2004-05 Impact factor: 5.958
Authors: Petra Kok; Ferdinand Roelfsema; Marijke Frölich; A Edo Meinders; Hanno Pijl Journal: J Clin Endocrinol Metab Date: 2005-08-09 Impact factor: 5.958
Authors: Mone Zaidi; Maria I New; Harry C Blair; Alberta Zallone; Ramkumarie Baliram; Terry F Davies; Christopher Cardozo; James Iqbal; Li Sun; Clifford J Rosen; Tony Yuen Journal: J Endocrinol Date: 2018-03-19 Impact factor: 4.286